Business Context and Reporting Period
Company: Charles River Laboratories International, Inc.
Filing Type: Form 8-K (Current Report)
Date of Report: February 18, 2026
Reporting Period: Fourth quarter and fiscal year ended December 27, 2025.
Key Financial Metrics
The filing text does not provide specific numerical values for revenue, profit, cash flow, margins, debt, or liquidity. This 8-K serves as a notification that financial results were issued via a press release (Exhibit 99.1), but the detailed metrics are not embedded in the body of this specific document.
Material Changes
The filing does not contain data to compare current results against prior periods. It references a press release containing the results but does not summarize the material changes within this text.
Guidance, Outlook, and Risks
- Forward-Looking Statements: The referenced press release includes "safe harbor" language under the Private Securities Litigation Reform Act of 1995, indicating the presence of forward-looking statements.
- Risks: The filing states that risks relating to the company are set forth in other documents filed with the SEC, but does not list specific risks or contingencies in this text.
- Unusual Items: No unusual items are described in the filing text.
Investor Verification Checklist
- Review Exhibit 99.1 (Press Release dated February 18, 2026) for actual revenue, earnings, and cash flow figures.
- Verify the specific forward-looking statements and associated risk factors detailed in the press release.
- Check the company's most recent 10-K or 10-Q for comparative historical data to assess material changes.
- Confirm the fiscal year-end date of December 27, 2025, for accurate period alignment.